RYTM
RYTM
NASDAQ · Biotechnology

Rhythm Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$115.63
+3.53 (+3.15%)
As of Aug 8, 9:49 PM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 20 91%
Hold 2 9%
Sell 0 0%
Price Target
Analyst Price Target -12.6% upside
Low Target $80.78
Average Target $101.09
High Target $123.16
Current Price $115.63
Current
$115.63
Target
$101.09
$80.78 $101.09 avg $123.16
Scenario Analysis
Bear Case
$80.78
-30.1%
Low target
Base Case
$101.09
-12.6%
Avg target
Bull Case
$123.16
+6.5%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$122.20
-5.4% from high
52-Week Low
$74.50
+55.2% from low
50-Day SMA
$105.86
+9.2% vs SMA
200-Day SMA
$92.90
+24.5% vs SMA
RSI (14)
49.1
Neutral
Target vs 52W High
$101.09
-17.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.0%